A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2011
08/24/2011	CN102164602A Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
08/24/2011	CN102164595A Nutritional support of the immune system during anti-cancer treatment
08/24/2011	CN102161984A Method for isolating tetramer uric acid oxydiazing enzyme
08/24/2011	CN102161754A Functional modification method for branched polyethylene glycol (PEG) derivative
08/24/2011	CN102161692A Improved hemostatic polypeptide and application thereof
08/24/2011	CN102161656A Caspase inhibitors and uses thereof
08/24/2011	CN102160895A Application of PITPNM3 gene in preparing medicine for inhibiting breast cancer invasion and transfer
08/24/2011	CN102160891A Hcv ns3-ns4a protease inhibition
08/24/2011	CN102160890A Pharmaceutical composition comprising an analgesic peptide
08/24/2011	CN101500512B Methods and compositions for repair of cartilage using an in vivo bioreactor
08/24/2011	CN101371917B Brain protein hydrolysate sodium chloride injection
08/24/2011	CN101209242B Recombination human epidermal growth factor spray and preparation method thereof
08/24/2011	CN101062947B Ciliary neurotrophy factor polypeptide allosteric and application thereof
08/24/2011	CN101015684B Recombinant erythropoietin liquor preparation
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011	US8003776 Mycobacterial antigens expressed during latency
08/23/2011	US8003764 Folliculin-specific antibodies and methods of detection
08/23/2011	US8003760 Factor VIII polymer conjugates
08/23/2011	US8003756 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
08/23/2011	US8003755 Hydrochloride salts of a glycopeptide phosphonate derivative
08/23/2011	US8003754 Paralytic peptide for use as a insecticide
08/23/2011	US8003753 Fret protease assays for clostridial toxins
08/23/2011	US8003697 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
08/23/2011	US8003688 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
08/23/2011	US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
08/23/2011	US8003630 Comprises therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin (opioid growth factor); cancer
08/23/2011	US8003628 Methods of inhibiting osteoclast activity
08/23/2011	US8003618 Focal calcium channel modulation
08/23/2011	US8003614 Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof
08/23/2011	US8003613 Methods and compositions for inducing apoptosis
08/23/2011	US8003612 Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disorders
08/23/2011	US8003611 Composite material useful as biomaterial and its preparation
08/23/2011	US8003610 Bradykinin B2 receptor antagonist peptide from amphibian skin
08/23/2011	US8003609 Method for ameliorating pain by modification of NMDA receptors through inhibition of Src
08/23/2011	US8003608 Using small molecule amino acid derivatives
08/23/2011	US8003607 HGF precursor protein variant and active protein thereof
08/23/2011	US8003606 Inhibiting serum response factor (SRF) to improve insulin sensitivity
08/23/2011	US8003605 Administration of an insulin derivative having a substituent containing from 6 to 40 carbon atoms attached to one of its amino acid residues.
08/23/2011	US8003604 Hepatitis C virus inhibitors
08/23/2011	US8003603 Angiogenin complexes (ANGex)
08/23/2011	US8003602 Antibacterial compounds
08/23/2011	US8003601 Pegylated mutated clostridium botulinum toxin
08/23/2011	US8003600 Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies
08/23/2011	US8003599 Inhibitors of L1 and ADAM10 for the treatment of carcinomas
08/23/2011	US8003598 Peptide anti-tumor agent
08/23/2011	US8003596 P-selectin targeting ligand and compositions thereof
08/23/2011	US8003595 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
08/23/2011	US8003389 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current
08/23/2011	US8003382 Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof
08/23/2011	US8003351 Activatable recombinant neurotoxins
08/23/2011	US8003347 Nucleic acids encoding ChemerinR ligands
08/23/2011	US8003345 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
08/23/2011	US8003334 Methods for identifying compounds which bind to TANGO294
08/23/2011	US8003134 Ascorbic acid composition and method for treatment of aging or damaged skin
08/23/2011	US8003133 Calcium phosphate delivery vehicles for osteoinductive proteins
08/23/2011	US8003114 AbfB-2 gene from Penicillium funiculosum
08/23/2011	US8003111 Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
08/23/2011	US8003109 Pharmaceutical compositions containing the long pentraxin PTX3
08/23/2011	US8003108 Sclerostin epitopes
08/23/2011	US8003104 Method for treating inflammation
08/23/2011	US8003101 Inflammatory mediator antagonists
08/23/2011	US8003096 Means and methods for the recruitment and identification of stem cells
08/23/2011	US8003095 Method of using lipid acyltransferase
08/23/2011	US8003094 Combination with a solvent, skin buffer and antioxidant to improve solubility and bioavailability for a variety of dosage forms
08/23/2011	US8003090 Method for inhibiting a microvascular complication by administering IL-6
08/23/2011	US8003089 Y shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
08/23/2011	CA2562756C Methods for controlling angiogenesis and cell proliferation using a desulphatohirudin
08/23/2011	CA2527646C Abuse resistant amphetamine compounds
08/23/2011	CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy
08/23/2011	CA2516018C Hepatitis c inhibitor peptide analogs
08/23/2011	CA2498572C Macrocyclic peptides active against the hepatitis c virus
08/23/2011	CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/23/2011	CA2473996C Methods and compositions for the promotion of hair growth utilizing actin binding peptides
08/23/2011	CA2456076C Integrin inhibitors for the treatment of eye diseases
08/23/2011	CA2449954C Dry powder inhalation system for transpulmonary administration
08/23/2011	CA2442159C Treatment using neublastin polypeptides
08/23/2011	CA2428278C Virulence of streptococci
08/23/2011	CA2415414C Particulate vectors for improving oral absorption of active principles
08/23/2011	CA2377209C Therapeutic peptide-based constructs
08/23/2011	CA2358107C Shelf-stable formulation of glucagon-like peptide-1
08/23/2011	CA2335488C Conformationally constrained backbone cyclized somatostatin analogs
08/23/2011	CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor
08/23/2011	CA2270877C Peptide-based immunotherapeutic agent
08/23/2011	CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
08/23/2011	CA2216098C Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution
08/23/2011	CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
08/23/2011	CA1341620C Envelope antigens of hiv-1
08/18/2011	WO2011100754A1 Live listeria-based vaccines for central nervous system therapy
08/18/2011	WO2011100688A1 Improved antagonists of muc1
08/18/2011	WO2011100585A1 Secondary structure stabilized nmda receptor modulators and uses thereof
08/18/2011	WO2011100543A2 Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
08/18/2011	WO2011100528A2 Compositions and uses of lectins
08/18/2011	WO2011100508A2 Methods and compositions related to glycoprotein-immunoglobulin fusions
08/18/2011	WO2011100460A2 Ccr7 ligand delivery and co-delivery in immunotherapy
08/18/2011	WO2011100455A1 Inhibition of antibody responses to foreign proteins
08/18/2011	WO2011100428A2 Compositions for improving bone mass
08/18/2011	WO2011100376A2 Methods and architecture for power optimization of iontophoretic transdermal drug delivery
08/18/2011	WO2011100362A1 Modified adam disintegrin domain polypeptides and uses thereof
08/18/2011	WO2011100234A2 Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods
08/18/2011	WO2011100233A2 Novel use of an il-12 receptor splice variant and molecular assay to quantify expression thereof

1 ... 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 ... 3163